1. Home
  2. CRIS vs HHS Comparison

CRIS vs HHS Comparison

Compare CRIS & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • HHS
  • Stock Information
  • Founded
  • CRIS 2000
  • HHS 1923
  • Country
  • CRIS United States
  • HHS United States
  • Employees
  • CRIS N/A
  • HHS N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • HHS Advertising
  • Sector
  • CRIS Health Care
  • HHS Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • HHS Nasdaq
  • Market Cap
  • CRIS 22.9M
  • HHS 26.9M
  • IPO Year
  • CRIS 2000
  • HHS N/A
  • Fundamental
  • Price
  • CRIS $1.61
  • HHS $3.40
  • Analyst Decision
  • CRIS Strong Buy
  • HHS
  • Analyst Count
  • CRIS 2
  • HHS 0
  • Target Price
  • CRIS $16.50
  • HHS N/A
  • AVG Volume (30 Days)
  • CRIS 72.1K
  • HHS 285.2K
  • Earning Date
  • CRIS 11-13-2025
  • HHS 11-13-2025
  • Dividend Yield
  • CRIS N/A
  • HHS N/A
  • EPS Growth
  • CRIS N/A
  • HHS N/A
  • EPS
  • CRIS N/A
  • HHS N/A
  • Revenue
  • CRIS $11,405,000.00
  • HHS $174,951,000.00
  • Revenue This Year
  • CRIS $2.72
  • HHS $6.54
  • Revenue Next Year
  • CRIS $8.27
  • HHS N/A
  • P/E Ratio
  • CRIS N/A
  • HHS N/A
  • Revenue Growth
  • CRIS 12.24
  • HHS N/A
  • 52 Week Low
  • CRIS $1.02
  • HHS $3.06
  • 52 Week High
  • CRIS $5.27
  • HHS $7.45
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 50.58
  • HHS 45.18
  • Support Level
  • CRIS $1.49
  • HHS $3.23
  • Resistance Level
  • CRIS $1.63
  • HHS $4.32
  • Average True Range (ATR)
  • CRIS 0.10
  • HHS 0.15
  • MACD
  • CRIS 0.01
  • HHS -0.00
  • Stochastic Oscillator
  • CRIS 68.87
  • HHS 22.02

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: